# Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

> **NCT01508104** · PHASE1 · TERMINATED · sponsor: **University of Cincinnati** · enrollment: 19 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** BEZ235
- **DRUG:** Everolimus

## Key facts

- **NCT ID:** NCT01508104
- **Lead sponsor:** University of Cincinnati
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2012-01
- **Primary completion:** 2014-02
- **Final completion:** 2014-12
- **Target enrollment:** 19 (ACTUAL)
- **Why stopped:** funding
- **Last updated:** 2017-08-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01508104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01508104, "Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT01508104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*